Literature DB >> 2898482

[External supramalleolar flap in the reconstructive surgery of the foot].

A C Masquelet1, M C Romaña.   

Abstract

The external supramalleolar flap is a mixed cutaneoaponeurotic flap removed from the external surface of lower part of leg and with, as its principal vascular pedicle, the anterior perforating branch of the peroneal artery. The flap can be used in two ways: as a rotation flap with distal cutaneous hinge allowing lover third of internal surface of leg and instep to be covered, or as a retrograde flux island flap by anastomosis of perforating artery to arteries of foot. The latter procedure is of interest in that it permits covering of loss of distal substance of foot in the dorsal or plantar region. Results of use of this method in 35 patients situate the place of the external supramalleolar flap in the techniques available for lower limb repair.

Entities:  

Mesh:

Year:  1988        PMID: 2898482

Source DB:  PubMed          Journal:  J Chir (Paris)        ISSN: 0021-7697


  4 in total

1.  Surgical anatomy of the lateral supramalleolar flap in arteritic patients: an anatomic study of 24 amputation specimens.

Authors:  S Malikov; D Casanova; G Magualon; A Branchereau
Journal:  Surg Radiol Anat       Date:  2003-04-25       Impact factor: 1.246

2.  [Lateral supramalleolar flaps for reconstruction in the ankle and foot].

Authors:  E L Hierner; C Corterier; R Hierner
Journal:  Oper Orthop Traumatol       Date:  2013-04       Impact factor: 1.154

3.  Anatomical basis of a fascio-cutaneous pedicle flap based on the infero-lateral collateral artery of the leg.

Authors:  D Le Nen; D Beal; H Person; C Lefevre; B Sénécail
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

4.  Fasciocutaneous flap with perforating branches of peroneal artery repairing soft tissue loss in anterior and middle parts of children's feet: A STROBE-compliant article.

Authors:  Wan-An Xiao; Wen-Liang Cao; Feng Tian; Li-Jie Tian
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.